CZA moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 33 of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on CZA as a result. In 69 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The 10-day moving average for CZA crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.
Following a +0.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where CZA advanced for three days, in 261 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 240 of 316 cases where CZA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CZA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
CZA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Moving Average Convergence Divergence (MACD) for FMC turned positive on October 30, 2026. Looking at past instances where FMC's MACD turned positive, the stock continued to rise in 34 of 47 cases over the following month. The odds of a continued upward trend are 72%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FMC's RSI Oscillator exited the oversold zone, 21 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 58%.
The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on FMC as a result. In 60 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where FMC advanced for three days, in 173 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
FMC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 53 cases where FMC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for FMC entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.535) is normal, around the industry mean (-0.492). P/E Ratio (-0.256) is within average values for comparable stocks, (8.794). Projected Growth (PEG Ratio) (1.532) is also within normal values, averaging (0.867). Dividend Yield (0.057) settles around the average of (0.126) among similar stocks. P/S Ratio (0.416) is also within normal values, averaging (1.476).
The Tickeron Price Growth Rating for this company is 66 (best 1 - 100 worst), indicating fairly steady price growth. FMC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
FMC | ||
|---|---|---|
OUTLOOK RATING 1..100 | 9 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 98 | |
PRICE GROWTH RATING 1..100 | 66 | |
P/E GROWTH RATING 1..100 | 10 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CZA | FMC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 68% | 2 days ago 58% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 68% |
| Momentum ODDS (%) | 4 days ago 80% | 2 days ago 69% |
| MACD ODDS (%) | N/A | 2 days ago 72% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 73% |
| TrendMonth ODDS (%) | 2 days ago 79% | 2 days ago 75% |
| Advances ODDS (%) | 2 days ago 80% | 2 days ago 60% |
| Declines ODDS (%) | 7 days ago 74% | 4 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 70% | 2 days ago 50% |
| Aroon ODDS (%) | 2 days ago 76% | 2 days ago 72% |
A.I.dvisor tells us that CZA and FMC have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CZA and FMC's prices will move in lockstep.
A.I.dvisor indicates that over the last year, FMC has been loosely correlated with CTVA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FMC jumps, then CTVA could also see price increases.
| Ticker / NAME | Correlation To FMC | 1D Price Change % | ||
|---|---|---|---|---|
| FMC | 100% | +0.18% | ||
| CTVA - FMC | 41% Loosely correlated | -0.25% | ||
| MOS - FMC | 32% Poorly correlated | -0.83% | ||
| NTR - FMC | 30% Poorly correlated | -0.72% | ||
| IPI - FMC | 22% Poorly correlated | -1.29% | ||
| BIOX - FMC | 20% Poorly correlated | +9.20% | ||
More | ||||